The Year Nitrosamine Contamination Went Beyond ARBs

]]>(MedPage Today) -- In March, we reported that a new generic valsartan (Diovan) hit the market to help the angiotensin receptor blocker (ARB) shortage caused by waves of recalls. In this follow-up, we take a look at the developments in the nitrosamine...